| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/28/2008 | US20080051360 Pkc ligands and polynucleotides encoding pkc ligands |
| 02/28/2008 | US20080051356 Truncated 24kDa basic fibroblast growth factor |
| 02/28/2008 | US20080051349 Peptide antagonists of zonulin and methods for use of the same |
| 02/28/2008 | US20080051347 Tumour-associated peptides binding to mhc-molecules |
| 02/28/2008 | US20080051346 Compounds and methods for modulating cell-adhesion mediated drug resistance |
| 02/28/2008 | US20080051345 Pharmaceutical compositions comprising fragments and homologs of troponin subunits |
| 02/28/2008 | US20080051344 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 02/28/2008 | US20080051340 Use of proteins and peptides of the TGF-Beta superfamily for purification and therapeutic methods |
| 02/28/2008 | US20080051338 98 Human Secreted Proteins |
| 02/28/2008 | US20080051337 Method for screening for anti-amyloidogenic properties and method for treatment of neurodegenerative disease |
| 02/28/2008 | US20080051336 Relaxin-3 Chimeric Polypeptides and Their Preparation and Use |
| 02/28/2008 | US20080051334 Diagnostic and Therapeutic Use of Kcnc1 for Neurodegenerative Diseases |
| 02/28/2008 | US20080051329 FSH and FSH variant formulations, products and methods |
| 02/28/2008 | US20080051328 Novel Muscle Growth Regulator |
| 02/28/2008 | US20080051327 Crystals of an Aurora-A Tpx2 Complex, Tpx2 Binding Site of Aurora-A, Aurora-A Ligands and Their Use |
| 02/28/2008 | US20080051325 Oligopeptide |
| 02/28/2008 | US20080051322 14400, 2838, 14618, 15334, 14274, 32164, 39404, 38911, 26904, 31237, 18057, 16405, 32705, 23224, 27423, 32700, 32712 and 12216, novel seven-transmembrane proteins/G-protein coupled receptors |
| 02/28/2008 | US20080051320 S-nitrosoprotein preparation and production method therefor |
| 02/28/2008 | US20080051299 DNA-protein fusions and uses thereof |
| 02/28/2008 | US20080050841 Peptides immunoreactive with autoantibodies from patients suffering from rheumatoid arthritis |
| 02/28/2008 | US20080050837 Diagnosing age related and cardiovascular disorders using variation in lamin a gene expression profiles; kits |
| 02/28/2008 | US20080050826 Method for improving corn starch extractability |
| 02/28/2008 | US20080050820 Casein kinase stress-related polypeptides and methods of use in plants |
| 02/28/2008 | US20080050811 Testicular carnitine transporter and its gene |
| 02/28/2008 | US20080050797 Transferase for use in identifying modulators for prevention and treatment of cell proliferative disorders |
| 02/28/2008 | US20080050795 Mixture Of At Least Two Different Antibodies Specific For Predetermined Antigens And Use Of The Mixture |
| 02/28/2008 | US20080050785 Method for Producing an L-Amino Acid |
| 02/28/2008 | US20080050784 Ability to produce L-glutamic acid, valine, threaonine, histidine or proline is incrreased by increasing expression of a specific protein, e.g., by increasing the copy number of the DNA coding for the protein |
| 02/28/2008 | US20080050778 Use to identify umami (e.g. MSG) and sweet taste modulatory compounds; e.g. screening for artificial sweeteners |
| 02/28/2008 | US20080050776 Stable mutated pro nerve growth factors |
| 02/28/2008 | US20080050774 Computer-based system for monitoring differential expression; host cells |
| 02/28/2008 | US20080050772 Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
| 02/28/2008 | US20080050770 Method for the production and purification of adenoviral vectors |
| 02/28/2008 | US20080050758 Genetic engineering; oligonucleotide detector; identification and isolation of novel DNA; transmembrane domain-deleted or transmembrane domain-inactivated protein; soluble extracellular domains; PRO polypeptide; cancer detection |
| 02/28/2008 | US20080050751 Nonhuman model animal of th2-mediated hyperimmune response |
| 02/28/2008 | US20080050716 Methods for preserving organs and tissues |
| 02/28/2008 | US20080050503 Expression of human milk proteins in transgenic plants |
| 02/28/2008 | US20080050406 Modified Dermatophagoides pteronyssinus allergen Der p 5 protein which inhibits immunoglobulin E (IgE) binding when exposed again to the antigen; treating allergies |
| 02/28/2008 | US20080050403 Production of viruses, viral isolates and vaccines |
| 02/28/2008 | US20080050402 comprising replacements in the influenza nonstructural 1 (NS1) polypeptide, that interferes with viral replication and phosphatidylinositol 3-kinase activation, used for treating and preventing influenza virus infection |
| 02/28/2008 | US20080050399 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins |
| 02/28/2008 | US20080050397 Multiple antigenic agents and methods for using the same |
| 02/28/2008 | US20080050396 useful in vaccine compositions for treatment of cancer; human major histocompatibility complex (MHC) Class I restricted peptides; kits |
| 02/28/2008 | US20080050393 Novel nucleic acids and polypeptides |
| 02/28/2008 | US20080050386 Novel proteins, gene encoding the same and method of utilization thereof |
| 02/28/2008 | US20080050383 Immunotherapy for clearing pathological tau conformers |
| 02/28/2008 | US20080050380 Glycoprotein VI and uses thereof |
| 02/28/2008 | US20080050377 consensus sequences and specific sequences for antibodies that specifically bind to STOP-1; angiogenesis and vasculogenesis; antitumor agents |
| 02/28/2008 | US20080050372 Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis |
| 02/28/2008 | US20080050369 Therapeutic applications of T-BAM (CD40L) technology to treat diseases involving smooth muscle cells |
| 02/28/2008 | US20080050363 Novel nucleic acid molecules encoding opioid growth factor receptors |
| 02/28/2008 | US20080050359 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 02/28/2008 | US20080050358 Identification of Snps Associated with Hyperlipidemia, Dyslipidemia and Defective Carbohydrate Metabolism |
| 02/28/2008 | US20080050351 Gene Therapy Approaches to Supply Apolipoprotein A-I Agonists and Their Use to Treat Dyslipidemic Disorder |
| 02/28/2008 | US20080050345 Adeno-associated virus serotype I nucleic acid sequences, vectors and host cells containing same |
| 02/28/2008 | US20080050343 Adeno-associated virus serotype I nucleic acid sequences, vectors and host cell containing same |
| 02/28/2008 | US20080050340 Cd40 agonist antibody /type 1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity |
| 02/28/2008 | US20080050311 Monoclonal Antibody hPAM4 |
| 02/28/2008 | US20080048052 Spray Nozzle Apparatus and Method of Use |
| 02/28/2008 | DE602004007105T2 Zusammensetzung zur behandlung von gastrointestinalen störungen Composition for the treatment of gastrointestinal disorders |
| 02/28/2008 | DE19955576B4 Transferverbindungen, ihre Herstellung und ihre Verwendung Transfer compounds, their preparation and their use |
| 02/28/2008 | DE102007040713A1 Hybrid material e.g. useful as an implant or bone substitute material comprises a collagen matrix stiffened and crosslinked by silicatization |
| 02/28/2008 | CA2661936A1 Soluble il-27 receptor |
| 02/28/2008 | CA2661814A1 Recombinant hcv e2 glycoprotein |
| 02/28/2008 | CA2661428A1 Biosilica-adhesive protein nanocomposite materials: synthesis and application in dentistry |
| 02/28/2008 | CA2661160A1 Specific and high affinity binding proteins comprising modified sh3 domains of fyn kinase |
| 02/28/2008 | CA2660696A1 Use of light sensitive genes |
| 02/28/2008 | CA2660668A1 Small cationic antimicrobial peptides |
| 02/28/2008 | CA2659993A1 Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains |
| 02/27/2008 | EP1892297A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 02/27/2008 | EP1892296A1 Generation and selection of recombinant varied binding proteins |
| 02/27/2008 | EP1892293A1 Transcription factor decoy |
| 02/27/2008 | EP1892252A2 Intermediate conductance, calcium-activated potassium channels and uses thereof |
| 02/27/2008 | EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/27/2008 | EP1892250A2 CYR61 compositions and methods |
| 02/27/2008 | EP1892249A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/27/2008 | EP1892248A1 Specific and high affinity binding proteins comprising modified SH3 domains of FYN kinase |
| 02/27/2008 | EP1892247A1 Dermopharmaceutical or cosmetic composition comprising enkephalin-derived peptides for reducing and/or eliminating facial wrinkles |
| 02/27/2008 | EP1892246A2 Antimicrobial peptides and method for identifying and using such peptides |
| 02/27/2008 | EP1891976A1 Use of light sensitive genes |
| 02/27/2008 | EP1891975A1 Anti-allergic complex molecules |
| 02/27/2008 | EP1891970A1 Beta glucan-based vaccines free of mannoprotein |
| 02/27/2008 | EP1891966A1 Modulation of activity of neurotrophins |
| 02/27/2008 | EP1891445A2 Method for diagnosing neurodegenerative disease |
| 02/27/2008 | EP1891444A2 Tirc7 as marker for detecting early immune activation |
| 02/27/2008 | EP1891224A1 Interferon-beta gene therapy using an improved, regulated expression system |
| 02/27/2008 | EP1891220A2 Autoactivated resistance protein |
| 02/27/2008 | EP1891217A2 Rna interference mediated inhibition of stromal cell-derived factor-1 (sdf-1) gene expression using short interfering nucleic acid (sina) |
| 02/27/2008 | EP1891212A2 Methods and compositions involving the s-ship promoter |
| 02/27/2008 | EP1891210A1 Dengue serotype 2 attenuated strain |
| 02/27/2008 | EP1891111A1 Il-31 monoclonal antibodies and methods of use |
| 02/27/2008 | EP1891108A1 Psp94 diagnostic reagents and assays |
| 02/27/2008 | EP1891107A2 Compositions and methods for modulating immune responses |
| 02/27/2008 | EP1891106A2 Novel compounds as glp-i agonists |
| 02/27/2008 | EP1891105A2 Oxyntomodulin analogues and their effects on feeding behaviour |
| 02/27/2008 | EP1891104A2 Solid phase bound thymosin alpha1 and its synthesis |
| 02/27/2008 | EP1891103A2 Mutant il-10 |
| 02/27/2008 | EP1891102A2 Fusion protein of antibody l19 against fibronectin ed-b and interleukin 12 |
| 02/27/2008 | EP1891101A2 Sclerostin binding agents |
| 02/27/2008 | EP1891100A2 Sclerostin epitopes |